Population Pharmacokinetics, Pharmacodynamics, and Exploratory Exposure–Response Analyses of Apixaban in Subjects Treated for Venous Thromboembolism

Apixaban is approved for treatment of venous thromboembolism (VTE) and prevention of recurrence. Population pharmacokinetics, pharmacokinetics–pharmacodynamics (anti‐FXa activity), and exposure–response (binary bleeding and thromboembolic endpoints) of apixaban in VTE treatment subjects were charact...

Descripción completa

Detalles Bibliográficos
Autores principales: Byon, W, Sweeney, K, Frost, C, Boyd, RA
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445237/
https://www.ncbi.nlm.nih.gov/pubmed/28547774
http://dx.doi.org/10.1002/psp4.12184

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5445237/
https://www.ncbi.nlm.nih.gov/pubmed/28547774
http://dx.doi.org/10.1002/psp4.12184

Ejemplares similares